Analyst Ratings for Globus Medical (GMED)
GMED Rating Summary
GMED Price Target Summary
- Highest: $123.00 (Barclays)
- Lowest: $82.00 (UBS)
- Average: $102.06
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$102.06 (+26.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$102.06 (+26.8%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | UBS | Matthew Taylor | New Coverage | Neutral (N/A) |
82.00 (N/A) |
78.25 (80.48) |
2.85% | Details |
| 7/8/2026 | BMO Capital | N/A | New Coverage | Outperform (N/A) |
N/A (N/A) |
78.83 (80.48) |
2.09% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


